Yadav, Sandhya
Gold, Laura S.
Zaidi, Qasim Hassan
Hwang, Raymond
Lu, Louie
Wang, Grace
Article History
Received: 2 January 2024
Accepted: 6 June 2024
First Online: 5 July 2024
Declarations
:
: The need for ethics approval was waived by Western Institutional Review Board (WIRB®), now known as WIRB-Copernicus Group (WCG® IRB) (OHRP/FDA IRB registration number IRB00000533) at 1019 39th Avenue SE Suite 120, Puyallup, Washington 98374–2115.
: The study does not involve human participants and instead utilizes de-identified claims data for analysis. The data used in the study is de-identified, meaning that it does not contain any personally identifiable information and thus does not require consent from individuals. Consent to participate was waived by Western Institutional Review Board (WIRB®), now known as WIRB-Copernicus Group (WCG® IRB), (OHRP/FDA IRB registration number IRB00000533) at 1019 39th Avenue SE Suite 120, Puyallup, Washington 98374–2115, considering the retrospective nature of the study.
: Written informed consent for publication was obtained for all human images included in the manuscript.
: SY, RH and LL are employed by and have equity interest in Hinge Health, Inc. and GW is a former employee with equity interest in Hinge Health, Inc. LG and QHZ declare that they have no competing interests.